W. Klapper

1.2k total citations
10 papers, 374 citations indexed

About

W. Klapper is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, W. Klapper has authored 10 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 2 papers in Genetics. Recurrent topics in W. Klapper's work include Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). W. Klapper is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). W. Klapper collaborates with scholars based in Germany, Poland and France. W. Klapper's co-authors include M-L Hansmann, Reiner Siebert, Erica Ballabio, Sara Tedoldi, Teresa Marafioti, Lorena Maestre, Stefano Pileri, Miguel Á. Piris, Jennifer C. Paterson and Giovanna Roncador and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

W. Klapper

9 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Klapper Germany 6 304 215 119 116 52 10 374
T Beck United States 3 265 0.9× 161 0.7× 149 1.3× 72 0.6× 19 0.4× 5 388
Sara Tedoldi United Kingdom 8 204 0.7× 169 0.8× 70 0.6× 177 1.5× 130 2.5× 9 429
Akito Dobashi Japan 9 205 0.7× 188 0.9× 47 0.4× 69 0.6× 69 1.3× 18 384
Tawatchai Pongpruttipan Thailand 10 281 0.9× 239 1.1× 37 0.3× 128 1.1× 106 2.0× 19 409
Kristina Hinz Germany 7 216 0.7× 107 0.5× 91 0.8× 60 0.5× 19 0.4× 16 304
Huiqiang Huang China 8 297 1.0× 267 1.2× 149 1.3× 90 0.8× 20 0.4× 20 460
Yuanxue Huang United Kingdom 9 218 0.7× 136 0.6× 124 1.0× 75 0.6× 16 0.3× 12 346
Iván Dlouhy Spain 12 437 1.4× 311 1.4× 130 1.1× 150 1.3× 97 1.9× 26 557
S H Swerdlow United States 6 283 0.9× 226 1.1× 171 1.4× 72 0.6× 32 0.6× 8 412

Countries citing papers authored by W. Klapper

Since Specialization
Citations

This map shows the geographic impact of W. Klapper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Klapper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Klapper more than expected).

Fields of papers citing papers by W. Klapper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Klapper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Klapper. The network helps show where W. Klapper may publish in the future.

Co-authorship network of co-authors of W. Klapper

This figure shows the co-authorship network connecting the top 25 collaborators of W. Klapper. A scholar is included among the top collaborators of W. Klapper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Klapper. W. Klapper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Koch, Karoline, Eva Hoster, Marita Ziepert, et al.. (2016). Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Annals of Oncology. 27(7). 1323–1329. 42 indexed citations
3.
Kluin‐Nelemans, Hanneke C., Eva Hoster, Olivier Hermine, et al.. (2011). R-CHOP VERSUS R-FC FOLLOWED BY MAINTENANCE WITH RITUXIMAB OR IFN: FIRST RESULTS OF A RANDOMIZED TRIAL FOR ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA. Annals of Oncology. 22. 86–86. 4 indexed citations
4.
Kluin‐Nelemans, Hanneke C., Eva Hoster, Jan Walewski, et al.. (2011). R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma. Blood. 118(21). 439–439. 20 indexed citations
5.
Guenther, Andreas, Pia Baumann, Renate Burger, et al.. (2010). Single-agent everolimus (RAD001) in patients with relapsed or refractory multiple myeloma: Final results of a phase I study.. Journal of Clinical Oncology. 28(15_suppl). 8137–8137. 3 indexed citations
7.
Hartmann, Sylvia, José I. Martı́n-Subero, Stefan Gesk, et al.. (2008). Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization. Haematologica. 93(9). 1318–1326. 76 indexed citations
9.
Roncador, Giovanna, Sara Tedoldi, Jennifer C. Paterson, et al.. (2007). Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica. 92(8). 1059–1066. 126 indexed citations
10.
Renné, Christoph, Klaus Willenbrock, José I. Martı́n-Subero, et al.. (2007). High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. Leukemia. 21(4). 780–787. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026